Iron activates NF-κB in Kupffer cells

被引:105
作者
She, HY
Xiong, SG
Lin, M
Zandi, E
Giulivi, C
Tsukamoto, H
机构
[1] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA
[3] Univ Minnesota, Dept Chem, Duluth, MN 55812 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2002年 / 283卷 / 03期
关键词
tumor necrosis factor-alpha; free radical; promoter; inhibitor kappa B kinase; electron paramagnetic resonance; nuclear factor-kappa B;
D O I
10.1152/ajpgi.00108.2002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Iron exacerbates various types of liver injury in which nuclear factor (NF)-kappaB-driven genes are implicated. This study tested a hypothesis that iron directly elicits the signaling required for activation of NF-kappaB and stimulation of tumor necrosis factor (TNF)-alpha gene expression in Kupffer cells. Addition of Fe2+ but not Fe3+ (similar to5-50 muM) to cultured rat Kupffer cells increased TNF-alpha release and TNF-alpha promoter activity in a NF-kappaB-dependent manner. C+ but not Cu2+ stimulated TNF-alpha protein release and promoter activity but with less potency. Fe2+ caused a disappearance of the cytosolic inhibitor kappaBalpha, a concomitant increase in nuclear p65 protein, and increased DNA binding of p50/p50 and p65/p50 without affecting activator protein-1 binding. Addition of Fe2+ to the cells resulted in an increase in electron paramagnetic resonance-detectable .OH peaking at 15 min, preceding activation of NF-kappaB but coinciding with activation of inhibitor kappaB kinase (IKK) but not c-Jun NH2-terminal kinase. In conclusion, Fe2+ serves as a direct agonist to activate IKK, NF-kappaB, and TNF-alpha promoter activity and to induce the release of TNF-alpha protein by cultured Kupffer cells in a redox status-dependent manner. We propose that this finding offers a molecular basis for iron-mediated accentuation of TNF-alpha-dependent liver injury.
引用
收藏
页码:G719 / G726
页数:8
相关论文
共 46 条
[1]   SEPARATION OF OXIDANT-INITIATED AND REDOX-REGULATED STEPS IN THE NF-KAPPA-B SIGNAL-TRANSDUCTION PATHWAY [J].
ANDERSON, MT ;
STAAL, FJT ;
GITLER, C ;
HERZENBERG, LA ;
HERZENBERG, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11527-11531
[2]   PHORBOL ESTER INDUCIBLE GENES CONTAIN A COMMON CIS ELEMENT RECOGNIZED BY A TPA-MODULATED TRANS-ACTING FACTOR [J].
ANGEL, P ;
IMAGAWA, M ;
CHIU, R ;
STEIN, B ;
IMBRA, RJ ;
RAHMSDORF, HJ ;
JONAT, C ;
HERRLICH, P ;
KARIN, M .
CELL, 1987, 49 (06) :729-739
[3]   A 65-KD SUBUNIT OF ACTIVE NF-KAPPA-B IS REQUIRED FOR INHIBITION OF NF-KAPPA-B BY I-KAPPA-B [J].
BAEUERLE, PA ;
BALTIMORE, D .
GENES & DEVELOPMENT, 1989, 3 (11) :1689-1698
[4]   Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees [J].
Bassett, SE ;
Di Bisceglie, AM ;
Bacon, BR ;
Sharp, RM ;
Govindarajan, S ;
Hubbard, GB ;
Brasky, KM ;
Lanford, RE .
HEPATOLOGY, 1999, 29 (06) :1884-1892
[5]   Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis [J].
Bonkovsky, HL ;
Jawaid, Q ;
Tortorelli, K ;
LeClair, P ;
Cobb, J ;
Lambrecht, RW ;
Banner, BF .
JOURNAL OF HEPATOLOGY, 1999, 31 (03) :421-429
[6]   INDUCTION OF FERRITIN SYNTHESIS BY OXIDATIVE STRESS - TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATION BY EXPANSION OF THE FREE IRON POOL [J].
CAIRO, G ;
TACCHINI, L ;
POGLIAGHI, G ;
ANZON, E ;
TOMASI, A ;
BERNELLIZAZZERA, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (02) :700-703
[7]  
CHAUDHRI G, 1989, J IMMUNOL, V143, P1290
[8]   REGULATION OF TUMOR NECROSIS FACTOR-ALPHA TRANSCRIPTION IN MACROPHAGES - INVOLVEMENT OF 4 KAPPA-B-LIKE MOTIFS AND OF CONSTITUTIVE AND INDUCIBLE FORMS OF NF-KAPPA-B [J].
COLLART, MA ;
BAEUERLE, P ;
VASSALLI, P .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (04) :1498-1506
[9]   DESFERAL ATTENUATES TNF RELEASE FOLLOWING HEPATIC ISCHEMIA/REPERFUSION [J].
COLLETTI, LM ;
REMICK, DG ;
CAMPBELL, DA .
JOURNAL OF SURGICAL RESEARCH, 1994, 57 (04) :447-453
[10]   Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial [J].
Di Bisceglie, AM ;
Bonkovsky, HL ;
Chopra, S ;
Flamm, S ;
Reddy, RK ;
Grace, N ;
Killenberg, P ;
Hunt, C ;
Tamburro, C ;
Tavill, AS ;
Ferguson, R ;
Krawitt, E ;
Banner, B ;
Bacon, BR .
HEPATOLOGY, 2000, 32 (01) :135-138